Lack of receptor activator of nuclear factor-κB ligand (RANKL) expression and functional production by human multiple myeloma cells

被引：0
|
作者：
Giuliani, M
Colla, S
Morandi, F
Barille-Nion, S
Rizzoli, V
机构：
[1] Univ Parma, Chair Hematol, I-43100 Parma, Italy
[2] Univ Parma, BMT Unit, I-43100 Parma, Italy
[3] INSERM, UMR 601, Nantes, France
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 02期
关键词：
RANKL; multiple myeloma;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [31] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Its Relationship to Coronary Atherosclerosis in HIV Patients
    Hwang, Janice J.
    Wei, Jeffrey
    Abbara, Suhny
    Grinspoon, Steven K.
    Lo, Janet
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (03) : 359 - 363
  • [32] The receptor activator of nuclear factor (NF)κB ligand (RANKL) is a new chemotactic factor for human monocytes
    Breuil, V
    Schmid-Antomarchi, H
    Schmid-Alliana, A
    Rezzonico, R
    Euller-Ziegler, L
    Rossi, B
    FASEB JOURNAL, 2003, 17 (10): : 1751 - +
  • [33] The receptor activator of nuclear factor (NF)κB ligand (RANKL) is a new chemotactic factor for human monocytes
    Breuil, V
    Schmid-Antomarchi, H
    Schmid-Alliana, A
    Euller-Ziegler, L
    Rossi, B
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S19 - S19
  • [34] In vitro expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in cultured equine articular cells
    Byron, Christopher R.
    Barger, Anne M.
    Stewart, Allison A.
    Pondenis, Holly C.
    Fan, Timothy M.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2010, 71 (06) : 615 - 622
  • [35] Receptor activator of nuclear factor-κB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells
    Mori, Kanji
    Berreur, Martine
    Blanchard, Frederic
    Chevalier, Catherine
    Guisle-Marsollier, Isabelle
    Masson, Martial
    Redini, Francoise
    Heymann, Dominique
    ONCOLOGY REPORTS, 2007, 18 (06) : 1365 - 1371
  • [36] Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma via Anti-Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets
    Zhang, Wenhua
    Xu, Siping
    Liu, Peng
    Li, Xusheng
    Yu, Xinyuan
    Kang, Bing
    MEDICINAL CHEMISTRY, 2024, 20 (07) : 733 - 740
  • [37] Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression
    Schubert, Antje
    Schulz, Hiltrud
    Emons, Guenter
    Gruendker, Carsten
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 331 - 338
  • [38] Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media
    Kuczkowski, Jerzy
    Sakowicz-Burkiewicz, Monika
    Izycka-Swieszewska, Ewa
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2010, 31 (06) : 404 - 409
  • [39] Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)
    Odkhuu, Erdenezaya
    Koide, Naoki
    Haque, Abedul
    Tsolmongyn, Bilegtsaikhan
    Naiki, Yoshikazu
    Hashimoto, Shoji
    Komatsu, Takayuki
    Yoshida, Tomoaki
    Yokochi, Takashi
    IMMUNOLOGY LETTERS, 2012, 142 (1-2) : 34 - 40
  • [40] Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
    Rinotas, Vagelis
    Liepouri, Fotini
    Ouzouni, Maria-Dimitra
    Chalkidi, Niki
    Papaneophytou, Christos
    Lampropoulou, Mariza
    Vidali, Veroniki P.
    Kontopidis, George
    Couladouros, Elias
    Eliopoulos, Elias
    Papakyriakou, Athanasios
    Douni, Eleni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
12345